Metoperil AT 25 Tablet contains Metoprolol Succinate 25mg + Amlodipine 5mg + Telmisartan 40mg, a combination medicine used for blood pressure management and cardiovascular risk reduction. It helps maintain heart health and prevent complications associated with hypertension.
Metoprolol, a beta-blocker, reduces heart rate and cardiac workload, Amlodipine, a calcium channel blocker, relaxes blood vessels, and Telmisartan, an angiotensin receptor blocker, lowers blood pressure further, providing a comprehensive cardiac care effect.
This tablet is commonly prescribed for patients needing lower-dose beta-blockade combined with effective vasodilation and angiotensin receptor inhibition, offering improved compliance and controlled blood pressure.
Metoperil AT 25 Tablet is valued for its triple-action mechanism, proven efficacy in hypertension management, and consistent clinical reliability, making it a preferred option for hospitals, clinics, and cardiovascular treatment programs.